The preferred method of ctDNA detection is through Next-Generation Sequencing (NGS), which has become a mandatory component in lung cancer management, being a standard in the detection of ALK, EGFR, and BRAF mutations amongst many others, which helps in making treatment decisions [7]. This evidence concerns the gene ALK and lung cancer.